Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 03/06/19941 min de leitura
Skin Protectant Drug Products for Over-The-Counter Human Use; Astringent Drug Products; Final Monograph
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is issuing a final rule amending the monograph for over-the-counter (OTC) astringent drug products. This amendment updates the monograph to incorporate a United States Pharmacopeia (U.S.P.) name change for an active ingredient included in the monograph. This final rule is part of the ongoing review of OTC drug products conducted by FDA.
Idioma original da fonte: Federal Register — Health and Human ServicesAbrir o comunicado original →